CPC technology class · C07
C07H — Sugars
Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids. 6,464 US utility patents granted 2015–2025, with the leading assignees and year-by-year filing trajectory.
- 6,464
- US patents granted
- C07
- Parent CPC class
- 20
- Active assignees
- -4%
- 5-yr velocity
CPC subclass C07H — SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS — covers 6,464 US utility patents granted between 2015 and 2025 according to USPTO PatentsView records. This subclass sits within the broader CPC class C07 (ORGANIC CHEMISTRY), one of roughly 250 top-level technology categories in the Cooperative Patent Classification system jointly maintained by the USPTO and the European Patent Office. At the subclass level, four-character codes like C07H give the most practical resolution for tracking a specific technology domain without losing sight of adjacent filings. Every grant here has been classified by a USPTO examiner based on the technical disclosure in the patent specification.
The competitive landscape in C07H is shaped by 20 distinct companies actively filing in this space. The Regents of the University of California leads with 97 patents, followed by President and Fellows of Harvard College at 1,824 grants and Life Technologies Corporation at 1,296. Concentration at the top of the leaderboard indicates whether this technology area is dominated by a handful of incumbents or fragmented across many filers — a useful signal for investors evaluating competitive moats and for product teams mapping freedom-to-operate risk.
Filing trajectory matters as much as static counts. The yearly series on this page plots grants from 2015 through 2025, highlighting whether innovation in C07H is accelerating, plateauing, or cooling. Technology areas with rising post-2020 activity often reflect emerging markets or new platform shifts, while declining filings can signal mature domains where incremental improvement has slowed. Researchers, licensing professionals, and competitive-intelligence teams use these patterns — together with the top-assignee distribution — to decide where to invest, where to license, and where to avoid entanglement. All counts on this page come directly from USPTO PatentsView and reflect US granted utility patents only.
Is C07H innovation accelerating?
US utility-patent grants per year in C07H, 2015–2025 — recent five years are down 4% versus 2015–2019.
Who leads C07H?
The 12 most active assignees in SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS — wider bars mean more grants
- Ionis Pharmaceuticals 271
Ionis Pharmaceuticals, Inc.
271 patents
- President and Fellows…
President and Fellows of Harvard College
1,824 patents
- Life
Life Technologies Corporation
1,296 patents
- Alnylam Pharmaceutica… 287
Alnylam Pharmaceuticals, Inc.
287 patents
- Gilead Sciences 561
Gilead Sciences, Inc.
561 patents
- The Trustees of Colum…
The Trustees of Columbia University in the City of New York
1,086 patents
- Illumina Cambridge 253
Illumina Cambridge Limited
253 patents
- Merck Sharp & Dohme
Merck Sharp & Dohme LLC
1,248 patents
- Pacific Biosciences O… 304
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
304 patents
- Glycom A/S 88
GLYCOM A/S
88 patents
- Conagen 58
Conagen Inc.
58 patents
- Purecircle Sdn Bhd 88
PureCircle Sdn Bhd
88 patents
What this shows The Regents of the Un… is the most active filer in C07H, holding 97 of the 6,464 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in C07H |
|---|---|---|
| #1 | Ionis Pharmaceuticals, Inc. | 271 |
| #2 | President and Fellows of Harvard College | 1,824 |
| #3 | Life Technologies Corporation | 1,296 |
| #4 | Alnylam Pharmaceuticals, Inc. | 287 |
| #5 | Gilead Sciences, Inc. | 561 |
| #6 | The Trustees of Columbia University in the City of New York | 1,086 |
| #7 | Illumina Cambridge Limited | 253 |
| #8 | Merck Sharp & Dohme LLC | 1,248 |
| #9 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 304 |
| #10 | GLYCOM A/S | 88 |
| #11 | Conagen Inc. | 58 |
| #12 | PureCircle Sdn Bhd | 88 |
| #13 | Bristol-Myers Squibb Company | 1,089 |
| #14 | The Trustees of the University of Pennsylvania | 1,264 |
| #15 | Sirna Therapeutics, Inc. | 72 |
| #16 | TRANSLATE BIO, INC. | 132 |
| #17 | Idenix Pharmaceuticals LLC | 38 |
| #18 | PFIZER INC. | 659 |
| #19 | EMORY UNIVERSITY | 512 |
| #20 | ENZO LIFE SCIENCES, INC. | 55 |
About This Class
CPC subclass C07H belongs to class C07.
6,464 patents were granted in this class between 2015 and 2025.
20 companies actively patent in this space.
Classification System
Cooperative Patent Classification (CPC) is a hierarchical patent classification system used by the USPTO and EPO.
Frequently Asked Questions
What is CPC class C07H?
How many patents have been filed in C07H?
Which company holds the most patents in C07H?
How is patent data for C07H collected?
What is the difference between CPC class and subclass?
Learn More
Explore the patent dataset
Read our methodology — how this data is sourced, computed, and verified.